BALTIMORE – February 4, 2014 – Warschawski, a full service branding, marketing, public relations, advertising and interactive agency, announced today that it has been retained by contract research organization, ImQuest Biosciences, Inc., as its marketing communications agency of record. Warschawski will be responsible for handling all marketing communications initiatives for ImQuest on a national level, including strategic planning, marketing, conducting media relations, securing speaking opportunities, managing its blog and e-newsletter, as well as planning and managing a series of events in celebration of the company’s 10th anniversary.

Based in Frederick, MD., ImQuest BioSciences is a pre-clinical contract research organization working in the biotechnology and pharmaceutical sector. With a goal of developing products that improve the lives of people throughout the world, ImQuest BioSciences provides expert contract research services to define the efficacy, toxicity and pharmaceutical properties of new and novel pharmaceutical products. The company specializes in the development of vaccines and biologic products for the treatment and prevention of infectious diseases, cancer and inflammatory disease and created the ImQuestSuccess platform, which helps to expedite the drug discovery and development process.

Warschawski and ImQuest BioSciences first partnered in April of 2013 to conduct branding research and refine ImQuest’s key messaging and brand positioning. Following the branding work, Warschawski was awarded the opportunity to redesign and launch a new website and update marketing collateral to align with the company’s new brand.

“We are thrilled to grow our relationship with ImQuest BioSciences. The results we achieved in creating their new website and collateral materials laid a great foundation for the brand. We’re looking forward to continuing that success and building ImQuest’s profile on a national scale,” commented David Warschawski, CEO of Warschawski. “We’re excited to create and execute integrated marketing communications programs throughout the year that will help ImQuest achieve its business goals.”

Warschawski is dedicated to providing clients with the highest quality of branding, marketing, PR, advertising, interactive and creative design services. Warschawski has won the top recognition of being named “U.S. Small Agency of the Year” for four of the past seven years. For ten consecutive years, it also has been ranked as one of the top 30 “Best Agencies to Work For” in the U.S. In 2010, Warschawski was named “U.S. Small Agency of the Year” and the “Best Small Agency to Work For” in the U.S. The company, whose clients include Fortune 500 and Inc. 500 companies, has won more than 200 awards for its marketing communications work over the last 15 years. Warschawski was founded in 1996 and is headquartered in Baltimore, MD.

ImQuest BioSciences, based in Frederick, Maryland, is a contract research organization (CRO) focused on the development of agents for the prevention and treatment of infectious disease, cancer, and inflammatory disease, as well as specialized capabilities to support the preformulation and formulation development for optimal product delivery. The company’s proprietary ImQuestSUCCESS platform has assisted their clients in expediting the development of products for clinical evaluation through rapid identification of candidates with a high probability of clinical success by reducing the risk associated with failure experienced during clinical development. ImQuest was named Small Business of the Year by the Tech Council of Maryland (2011) and Best Places to Work (2012) by Frederick County, Maryland. Robert W. Buckheit, Jr., Ph.D., Founder and President, was Frederick’s Entrepreneur of the Year in 2011.